6821 - 6830 of 8620 Results
Title
Year
-
OPENTitle: DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1061End Page: 1074Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13239Best OA location URL: http://europepmc.org/pmc/articles/PMC8485588Citation Count: 36
-
OPENTitle: Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette SyndromeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 5Start Page: 694End Page: 700Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13207Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8287163Citation Count: 7
-
OPENTitle: The Role of Focused Ultrasound in the Management of Movement Disorders: Insights after 5 Years of ExperienceJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 5Start Page: 681End Page: 687Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13223Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8287154Citation Count: 10
- Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study2021OPENTitle: Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1853End Page: 1862Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28596Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28596Citation Count: 38
-
OPENTitle: Urodynamic Evaluation in Multiple System Atrophy: A Retrospective Cohort StudyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1052End Page: 1060Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13307Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13307Citation Count: 11
-
OPENTitle: Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 119End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28814Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/dc04516a-d43f-4a65-914b-0c5d09b9e5d8Citation Count: 25
- Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment2021RESTRICTEDTitle: Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression TreatmentJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2549End Page: 2558Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28548Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11822725Citation Count: 38
-
OPENTitle: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1704End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28569Best OA location URL: https://hal.science/hal-03190779Citation Count: 21
-
OPENTitle: Non‐Motor Fluctuations in Parkinson's Disease: Validation of the Non‐Motor Fluctuation Assessment QuestionnaireJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1392End Page: 1400Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28507Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28507Citation Count: 37
-
OPENTitle: Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2675End Page: 2681Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28749Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28749Citation Count: 31